Administer Bempedoic Acid 180 mg & Ezetimibe 10 mg tablet orally once daily with or without food. The safety and effectiveness of this tablet have not been established in pediatric patients.
Administer Bempedoic Acid 180 mg & Ezetimibe 10 mg tablet orally once daily with or without food. The safety and effectiveness of this tablet have not been established in pediatric patients.
This is contraindicated in patients with a known hypersensitivity to ezetimibe tablets. Hypersensitivity reactions including anaphylaxis, angioedema, rash and urticaria have been reported with ezetimibe
- Upper respiratory tract infection
- Muscle Spasms
- Hyperuricemia
- Back pain
- Abdominal pain or discomfort
- Bronchitis
- Pain in extremity
- Anemia
- Elevated liver enzymes
Discontinue Bempedoic Acid & Ezetimibe when pregnancy is recognized unless the benefits of therapy outweigh the potential risk to the fetus. There are no available data on Bempedoic Acid & Ezetimibe use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There is no information regarding the presence of Bempedoic Acid & Ezetimibe in human or animal milk, the effects of the drug on the breastfeed infant,or the effects of the drug on milk production. Breastfeeding is not recommended during treatment with Bempedoic Acid & Ezetimibe.
Other Anti-anginal & Anti-ischaemic drugs
Available Brand Names
Unit Price: ৳ 35.00 (3 x 10: ৳ 1,050.00)